Jane Ussher: Challenging Medicalization of Postpartum Depression
Jane Ussher, Professor of Women’s Health Psychology at Western Sydney University, shared a post on LinkedIn about a paper by Lisa Cosgrove et al. published in Women’s Reproductive Health:
“Using zuranolone as a case study, this paper shows how industry and academia reinforce the medicalisation of women’s distress, overstating benefits while downplaying harms, and deflecting attention from the social and economic drivers of postpartum suffering.”
Title: Take Back the Narrative: What Women and Healthcare Providers Need to Know About the “First-Ever” Pill for Postpartum Depression
Authors: Lisa Cosgrove, Fiona Wu, Maeve Silman, Edie Gobel, Emilija Jankov, Lena Matković, Marija Milovanović, Dinah Akua Odea Ansah
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 22, 2026, 17:50New Research on Oocyte Quality Challenges in DOR – RBMO
-
Feb 22, 2026, 06:58Ronell Martz: Fertility Preservation CME with Maria Costantini-Ferrando
-
Feb 22, 2026, 06:25Master Embryo Transfer Techniques at EFRE Conference 2026 – EFRE
-
Feb 22, 2026, 06:11New Insights into Comorbidities in Adenomyosis Patients – RBMO
-
Feb 22, 2026, 06:02New Evidence-Based Recommendations on Infertility – ESHRE
-
Feb 22, 2026, 05:54Sadashiva Pai: Breakthroughs in Ovarian Microenvironment for Infertility
-
Feb 22, 2026, 05:47Revolutionizing Uterine Drug Development with Dynamic Imaging – Fidēs Imaging
-
Feb 22, 2026, 05:34Kevin Lee: Bridging the Recognition Gap for ME/CFS Patients
-
Feb 22, 2026, 04:58Christy Kenady: Innovations in Women’s Health for Military Servicewomen
